Filing Details
- Accession Number:
- 0001104659-15-050292
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-08 15:04:55
- Reporting Period:
- 2015-07-06
- Filing Date:
- 2015-07-08
- Accepted Time:
- 2015-07-08 15:04:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428522 | Radius Health Inc. | RDUS | Pharmaceutical Preparations (2834) | 800145732 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1406337 | Kurt Graves | C/O Radius Health, Inc. 950 Winter St. Waltham MA 02145 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-07-06 | 25,000 | $7.34 | 25,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-07-06 | 25,000 | $69.48 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2015-07-06 | 25,000 | $0.00 | 25,000 | $7.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
27,723 | 2014-01-01 | 2021-11-06 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2015.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $67.12 to $70.60. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This option was previously reported as covering 177,209 shares at an exercise price of $3.22 per share, but was adjusted to reflect the stock split that occurred on April 24, 2014.